SeaStar Medical Holding Corp
ICU Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$2.47
KIRA · Stoqly’s AI analyst, in plain words
- SeaStar Medical Holding Corp had $1.2M of revenue in fiscal 2025, up 814.1% on the year before.
- Its operating margin was −986.6%, up 12,229.7 pts: of every 100 in sales, about −987 is left after running the business.
- SeaStar Medical Holding Corp lost $12.2M in fiscal 2025.
Market cap
—
P/E
—
Revenue
$1.2M
Net income
−$12.2M
Free cash flow
—
Operating margin
−986.6%
SeaStar Medical Holding Corp in 30 seconds · fiscal 2025
Are sales growing?
+814.1%
Yes. Sales grew 814.1% last year.
Does it make a profit?
−984.6%
No. It lost money last year.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
What SeaStar Medical Holding Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 25, 2026
- Legal name
- SeaStar Medical Holding Corp
- CIK
- 0001831868
SeaStar Medical Holding Corp · ICU
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | — | — | $0.0M | $0.1M | $1.2M |
| Revenue growth | — | — | — | — | 814.1% |
| Gross margin | — | — | — | 100.0% | 95.7% |
| Operating margin | — | — | — | −13,216.3% | −986.6% |
| Net income | −$4.6M | −$12.2M | −$26.2M | −$24.8M | −$12.2M |
| Net margin | — | — | — | −18,392.6% | −984.6% |
| Diluted EPS | −$0.63 | −$1.48 | −$30.26 | −$6.63 | — |
| Cash | |||||
| Cash from operations | −$5.1M | −$7.8M | −$10.3M | −$16.0M | −$13.6M |
| Share count change | — | 13.4% | −89.4% | 331.9% | — |
| Debt and strength | |||||
| Cash and short-term investments | $0.1M | $0.0M | $0.2M | $1.8M | $12.0M |
| Debt incl. finance leases | — | $7.7M | $4.1M | $0.6M | — |
| Shareholders' equity | −$2.8M | −$20.8M | −$13.9M | −$2.2M | $10.4M |
| Current ratio | 0.2x | 0.1x | 0.2x | 0.6x | 3.6x |
| Interest coverage | −21.0x | −18.4x | −13.1x | −73.1x | −392.7x |
| Returns and quality | |||||
| Return on equity | — | — | — | — | −295.2% |
| Return on tangible equity | — | — | — | — | −116.6% |
| Piotroski F-score | — | — | 4 | 5 | 3 |
| Altman Z'' | −490.4 | −153.2 | −154.5 | −128.1 | −33.2 |
Insiders bought, 12 months
$0.0M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
SeaStar Medical Holding Corp · ICU
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.47 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001831868). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.